Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

DOI DOI DOI DOI HANDLE ほか22件をすべて表示 一部だけ表示 研究データあり 被引用文献29件 参考文献519件 オープンアクセス
  • Joshua A. Welsh
    Translational Nanobiology Section, Laboratory of Pathology National Cancer Institute, National Institutes of Health Bethesda Maryland USA
  • Deborah C. I. Goberdhan
    Nuffield Department of Women's and Reproductive Health University of Oxford, Women's Centre, John Radcliffe Hospital Oxford UK
  • Lorraine O'Driscoll
    School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Dublin Ireland
  • Edit I. Buzas
    Department of Genetics, Cell‐ and Immunobiology Semmelweis University Budapest Hungary
  • Cherie Blenkiron
    Faculty of Medical and Health Sciences The University of Auckland Auckland New Zealand
  • Benedetta Bussolati
    Department of Molecular Biotechnology and Health Sciences University of Turin Turin Italy
  • Houjian Cai
    University of Georgia Athens Georgia USA
  • Dolores Di Vizio
    Department of Surgery, Division of Cancer Biology and Therapeutics Cedars‐Sinai Medical Center Los Angeles California USA
  • Tom A. P. Driedonks
    Department CDL Research University Medical Center Utrecht Utrecht The Netherlands
  • Uta Erdbrügger
    University of Virginia Health System Charlottesville Virginia USA
  • Juan M. Falcon‐Perez
    Exosomes Laboratory, Center for Cooperative Research in Biosciences Basque Research and Technology Alliance Derio Spain
  • Qing‐Ling Fu
    Otorhinolaryngology Hospital, The First Affiliated Hospital Sun Yat‐sen University Guangzhou China
  • Andrew F. Hill
    Institute for Health and Sport Victoria University Melbourne Australia
  • Metka Lenassi
    Faculty of Medicine University of Ljubljana Ljubljana Slovenia
  • Sai Kiang Lim
    Institute of Molecular and Cell Biology (IMCB) Agency for Science, Technology and Research (A*STAR) Singapore Singapore
  • Mỹ G. Mahoney
    Thomas Jefferson University Philadelphia Pennsylvania USA
  • Sujata Mohanty
    Stem Cell Facility All India Institute of Medical Sciences New Delhi India
  • Andreas Möller
    Chinese University of Hong Kong Hong Kong Hong Kong S.A.R.
  • Rienk Nieuwland
    Laboratory of Experimental Clinical Chemistry, Amsterdam University Medical Centers, Location AMC University of Amsterdam Amsterdam The Netherlands
  • Takahiro Ochiya
    Tokyo Medical University Tokyo Japan
  • Susmita Sahoo
    Icahn School of Medicine at Mount Sinai New York New York USA
  • Ana C. Torrecilhas
    Laboratório de Imunologia Celular e Bioquímica de Fungos e Protozoários, Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas Universidade Federal de São Paulo (UNIFESP) Campus Diadema Diadema Brazil
  • Lei Zheng
    Department of Laboratory Medicine, Nanfang Hospital Southern Medical University Guangzhou China
  • Andries Zijlstra
    Department of Pathology Vanderbilt University Medical Center Nashville Tennessee USA
  • Sarah Abuelreich
    Department of Molecular Medicine, Beckman Research Institute City of Hope Comprehensive Cancer Center Duarte California USA
  • Reem Bagabas
    Department of Molecular Medicine, Beckman Research Institute City of Hope Comprehensive Cancer Center Duarte California USA
  • Paolo Bergese
    Department of Molecular and Translational Medicine University of Brescia Brescia Italy
  • Esther M. Bridges
    Weatherall Institute of Molecular Medicine University of Oxford Oxford UK
  • Marco Brucale
    Consiglio Nazionale delle Ricerche ‐ Istituto per lo Studio dei Materiali Nanostrutturati Bologna Italy
  • Dylan Burger
    Kidney Research Centre Ottawa Hopsital Research Institute Ottawa Canada
  • Randy P. Carney
    Department of Biomedical Engineering University of California Davis California USA
  • Emanuele Cocucci
    Division of Pharmaceutics and Pharmacology, College of Pharmacy The Ohio State University Columbus Ohio USA
  • Rossella Crescitelli
    Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences Sahlgrenska Academy, University of Gothenburg Gothenburg Sweden
  • Edveena Hanser
    Department of Biomedicine University Hospital Basel Basel Switzerland
  • Adrian L. Harris
    Department of Oncology University of Oxford Oxford UK
  • Norman J. Haughey
    Departments of Neurology and Psychiatry Johns Hopkins University School of Medicine Baltimore Maryland USA
  • An Hendrix
    Laboratory of Experimental Cancer Research, Department of Human Structure and Repair Ghent University Ghent Belgium
  • Alexander R. Ivanov
    Barnett Institute of Chemical and Biological Analysis, Department of Chemistry and Chemical Biology Northeastern University Boston Massachusetts USA
  • Tijana Jovanovic‐Talisman
    Department of Cancer Biology and Molecular Medicine, Beckman Research Institute City of Hope Comprehensive Cancer Center Duarte California USA
  • Nicole A. Kruh‐Garcia
    Bio‐pharmaceutical Manufacturing and Academic Resource Center (BioMARC) Infectious Disease Research Center, Colorado State University Fort Collins Colorado USA
  • Vroniqa Ku'ulei‐Lyn Faustino
    Department of Molecular Medicine, Beckman Research Institute City of Hope Comprehensive Cancer Center Duarte California USA
  • Diego Kyburz
    Department of Biomedicine University of Basel Basel Switzerland
  • Cecilia Lässer
    Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition Institute of Medicine at Sahlgrenska Academy, University of Gothenburg Gothenburg Sweden
  • Kathleen M. Lennon
    Department of Molecular Medicine, Beckman Research Institute City of Hope Comprehensive Cancer Center Duarte California USA
  • Jan Lötvall
    Krefting Research Centre, Institute of Medicine at Sahlgrenska Academy University of Gothenburg Gothenburg Sweden
  • Adam L. Maddox
    Department of Molecular Medicine, Beckman Research Institute City of Hope Comprehensive Cancer Center Duarte California USA
  • Elena S. Martens‐Uzunova
    Erasmus MC Cancer Institute University Medical Center Rotterdam, Department of Urology Rotterdam The Netherlands
  • Rachel R. Mizenko
    Department of Biomedical Engineering University of California Davis California USA
  • Lauren A. Newman
    College of Medicine and Public Health Flinders University Adelaide Australia
  • Andrea Ridolfi
    Department of Physics and Astronomy, and LaserLaB Amsterdam Vrije Universiteit Amsterdam Amsterdam The Netherlands
  • Eva Rohde
    Department of Transfusion Medicine, University Hospital Salzburger Landeskliniken GmbH of Paracelsus Medical University Salzburg Austria
  • Tatu Rojalin
    Department of Biomedical Engineering University of California Davis California USA
  • Andrew Rowland
    College of Medicine and Public Health Flinders University Adelaide Australia
  • Andras Saftics
    Department of Molecular Medicine, Beckman Research Institute City of Hope Comprehensive Cancer Center Duarte California USA
  • Ursula S. Sandau
    Department of Anesthesiology & Perioperative Medicine Oregon Health & Science University Portland Oregon USA
  • Julie A. Saugstad
    Department of Anesthesiology & Perioperative Medicine Oregon Health & Science University Portland Oregon USA
  • Faezeh Shekari
    Department of Stem Cells and Developmental Biology, Cell Science Research Center Royan Institute for Stem Cell Biology and Technology, ACECR Tehran Iran
  • Simon Swift
    Waipapa Taumata Rau University of Auckland Auckland New Zealand
  • Dmitry Ter‐Ovanesyan
    Wyss Institute for Biologically Inspired Engineering Harvard University Boston Massachusetts USA
  • Juan P. Tosar
    Universidad de la República Montevideo Uruguay
  • Zivile Useckaite
    College of Medicine and Public Health Flinders University Adelaide Australia
  • Francesco Valle
    Consiglio Nazionale delle Ricerche ‐ Istituto per lo Studio dei Materiali Nanostrutturati Bologna Italy
  • Zoltan Varga
    Biological Nanochemistry Research Group Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences Budapest Hungary
  • Edwin van der Pol
    Amsterdam Vesicle Center, Amsterdam University Medical Centers, Location AMC University of Amsterdam Amsterdam The Netherlands
  • Martijn J. C. van Herwijnen
    Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands
  • Marca H. M. Wauben
    Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands
  • Ann M. Wehman
    University of Denver Denver USA
  • Sarah Williams
    International Society for Extracellular Vesicles
  • Andrea Zendrini
    Department of Molecular and Translational Medicine University of Brescia Brescia Italy
  • Alan J. Zimmerman
    Barnett Institute of Chemical and Biological Analysis, Department of Chemistry and Chemical Biology Northeastern University Boston Massachusetts USA
  • Clotilde Théry
    Institut Curie, INSERM U932 PSL University Paris France
  • Kenneth W. Witwer
    Department of Molecular and Comparative Pathobiology Johns Hopkins University School of Medicine Baltimore Maryland USA

書誌事項

公開日
2024-02
資源種別
journal article
権利情報
  • http://creativecommons.org/licenses/by/4.0/
DOI
  • 10.1002/jev2.12404
  • 10.26181/25723152
  • 10.26181/25723152.v1
  • 10.21256/zhaw-29924
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year‐on‐year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non‐vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its ‘Minimal Information for Studies of Extracellular Vesicles’, which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly.</jats:p>

収録刊行物

被引用文献 (29)*注記

もっと見る

参考文献 (519)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

問題の指摘

ページトップへ